Skip to main content
Livermore
Livermore
ZHEN

Affinity Asset Advisors, LLC

SEC CIK
0001773195
Latest filing
Aug 13, 2026

Holdings in Q2 2023

Holdings as of Jun 30, 2023, filed Aug 21, 2023. Long positions only; changes compare share counts with Q1 2023.

Institution overview
Positions
62
−1 vs. Q1 2023
Portfolio value
$254.1M
−$6.12M (−2.4%) vs. Q1 2023
Filed
Aug 21, 2023
AmendedSEC
Holdings of Affinity Asset Advisors, LLC in Q2 2023
SecurityClassSharesValue% of portfolioShare changeActionHistory
Rocket Pharmaceuticals, Inc.77313F114*W EXP 09/02/20275,000$13.9K<0.1%00.0%Unchanged–
NAMSWNewAmsterdam Pharma Co N.V.*W EXP 11/22/20237,000$77.3K<0.1%00.0%UnchangedHistory
CNTXContext Therapeutics Inc.COM267,574$428.1K0.2%+267,574NewHistory
NLS Pharmaceutics LtdH57830103SHS400,000$440.0K0.2%+55,911+16.2%Added–
NUVBNuvation Bio Inc.COM CL A250,000$450.0K0.2%00.0%UnchangedHistory
VIRVir Biotechnology, Inc.COM20,000$490.6K0.2%+20,000NewHistory
BBIOBridgeBio Pharma, Inc.COM35,133$604.3K0.2%−284,867−89.0%ReducedHistory
TRMLTourmaline Bio, Inc.COM200,000$608.0K0.2%+200,000NewHistory
Immatics N.V.N44445117*W EXP 07/01/202187,204$632.8K0.2%00.0%Unchanged–
JSPRJasper Therapeutics, Inc.COM476,948$653.4K0.3%00.0%UnchangedHistory
PCVXVaxcyte, Inc.COM13,923$695.3K0.3%−48,300−77.6%ReducedHistory
PBYIPuma Biotechnology, Inc.COM202,349$714.3K0.3%+25,000+14.1%AddedHistory
MIRMMirum Pharmaceuticals, Inc.COM30,000$776.1K0.3%−65,000−68.4%ReducedHistory
MISTMilestone Pharmaceuticals Inc.COM300,068$855.2K0.3%+100,686+50.5%AddedHistory
AXSMAxsome Therapeutics, Inc.COM12,500$898.3K0.4%+12,500NewHistory
APLSApellis Pharmaceuticals, Inc.COM10,000$911.0K0.4%−25,000−71.4%ReducedHistory
BCABBioAtla, Inc.COM325,000$975.0K0.4%00.0%UnchangedHistory
NRIXNurix Therapeutics, Inc.COM100,000$999.0K0.4%−50,000−33.3%ReducedHistory
MLYSMineralys Therapeutics, Inc.COM62,500$1.07M0.4%00.0%UnchangedHistory
IFRXInflaRx N.V.COM240,200$1.07M0.4%+240,200NewHistory
NAMSNewAmsterdam Pharma Co N.V.ORDINARY SHARES100,000$1.19M0.5%+100,000NewHistory
ALPNAlpine Immune Sciences, Inc.COM118,891$1.22M0.5%−129,000−52.0%ReducedHistory
ALDXAldeyra Therapeutics, Inc.COM150,000$1.26M0.5%+150,000NewHistory
WHWKWhitehawk Therapeutics, Inc.COM187,675$1.28M0.5%+187,675NewHistory
ADCTADC Therapeutics SASHS600,000$1.29M0.5%00.0%UnchangedHistory
Intrexon Corp46122TAA0NOTE 3.500% 7/0–$1.51M0.6%–––
KALVKalVista Pharmaceuticals, Inc.COM178,292$1.60M0.6%−30,000−14.4%ReducedHistory
CABACabaletta Bio, Inc.COM125,000$1.61M0.6%+125,000NewHistory
LIANYLianBioSPONSORED ADS800,676$1.83M0.7%+150,676+23.2%AddedHistory
VINCVincerx Pharma, Inc.COM NEW1,492,771$1.94M0.8%00.0%UnchangedHistory
SYRESpyre Therapeutics, Inc.COM4,900,000$2.21M0.9%+4,900,000NewHistory
THRXTheseus Pharmaceuticals, Inc.COM240,244$2.24M0.9%+142,023+144.6%AddedHistory
XENEXenon Pharmaceuticals Inc.COM60,376$2.32M0.9%−29,624−32.9%ReducedHistory
KYNBKyntra Bio, Inc.COM983,300$2.65M1.0%+983,300NewHistory
CLDXCelldex Therapeutics, Inc.COM NEW87,031$2.95M1.2%+37,031+74.1%AddedHistory
RETAReata Pharmaceuticals IncCL A29,105$2.97M1.2%+29,105NewHistory
VTYXVentyx Biosciences, Inc.COM100,696$3.30M1.3%−159,312−61.3%ReducedHistory
SWTXSpringWorks Therapeutics, Inc.COM130,000$3.41M1.3%+130,000NewHistory
Esperion Therapeutics Inc Ne29664WAB1NOTE 4.000%11/1–$3.44M1.4%–––
IMTXImmatics N.V.SHS300,000$3.46M1.4%+300,000NewHistory
AUTLAutolus Therapeutics plcSPON ADS1,589,017$3.78M1.5%+1,589,017NewHistory
CYTKCytokinetics IncCOM NEW125,148$4.08M1.6%−96,315−43.5%ReducedHistory
INZYInozyme Pharma, Inc.COM751,796$4.19M1.6%00.0%UnchangedHistory
AZNAstraZeneca PLCSPONSORED ADR60,000$4.29M1.7%00.0%UnchangedHistory
VKTXViking Therapeutics, Inc.COM300,000$4.86M1.9%−322,249−51.8%ReducedHistory
IMVTImmunovant, Inc.COM260,000$4.93M1.9%+260,000NewHistory
ASNDAscendis Pharma A/SSPONSORED ADR57,760$5.16M2.0%+17,760+44.4%AddedHistory
ATXSAstria Therapeutics, Inc.COM650,875$5.42M2.1%+121,506+23.0%AddedHistory
CNTACentessa Pharmaceuticals plcSPONSORED ADS900,723$5.58M2.2%+216,596+31.7%AddedHistory
PRTAProthena Corp Public Ltd CoSHS100,000$6.83M2.7%+100,000NewHistory
ACLXArcellx, Inc.COMMON STOCK226,275$7.15M2.8%+23,441+11.6%AddedHistory
BridgeBio Pharma, Inc.10806XAB8NOTE 2.500% 3/1–$9.45M3.7%–––
VRNAVerona Pharma plcSPONSORED ADS447,667$9.46M3.7%−5,154−1.1%ReducedHistory
KURAKura Oncology, Inc.COM910,317$9.63M3.8%+553,030+154.8%AddedHistory
BIIBBiogen Inc.COM40,000$11.4M4.5%+40,000NewHistory
CBAYCymaBay Therapeutics, Inc.COM1,050,118$11.5M4.5%−33,000−3.0%ReducedHistory
MORFMorphic Holding, Inc.COM201,887$11.6M4.6%+66,024+48.6%AddedHistory
TEVATeva Pharmaceutical Industries LtdSPONSORED ADS1,600,000$12.0M4.7%+1,600,000NewHistory
KDNYChinook Therapeutics, Inc.COM321,017$12.3M4.9%−655,004−67.1%ReducedHistory
ESTAEstablishment Labs Holdings Inc.COM211,608$14.5M5.7%+98,384+86.9%AddedHistory
CERECerevel Therapeutics Holdings, Inc.COM550,000$17.5M6.9%+170,000+44.7%AddedHistory
MDGLMadrigal Pharmaceuticals, Inc.COM92,500$21.4M8.4%−500−0.5%ReducedHistory

Options (6)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Affinity Asset Advisors, LLC in Q2 2023
SecurityClassPutsCalls
MDGLMadrigal Pharmaceuticals, Inc.COM–$12.3M
BBIOBridgeBio Pharma, Inc.COM$6.47M–
VKTXViking Therapeutics, Inc.COM$5.67M–
KYNBKyntra Bio, Inc.COM$2.65M$918.0K
VRDNViridian Therapeutics, Inc.COM–$3.10M
ARAVAravive, Inc.COM$1.09M$42.3K

Sold out since Q1 2023 (20)

Positions held at the end of Q1 2023 that are gone from this filing.

Positions of Affinity Asset Advisors, LLC sold out since Q1 2023
SecurityClassShares in Q1 2023Value in Q1 2023% of portfolio in Q1 2023History
RXDXPrometheus Biosciences, Inc.COM150,000$16.1M6.2%History
MRKMerck & Co., Inc.Stock120,000$12.8M4.9%History
BridgeBio Pharma, Inc.10806XAD4NOTE 2.250% 2/0–$7.12M2.7%–
Bellus Health Inc New07987C204COM NEW881,329$6.35M2.4%–
SGENSeagen Inc.COM20,000$4.05M1.6%History
ARGXArgenx SESPONSORED ADR10,750$4.01M1.5%History
ETNB89bio, Inc.COM200,000$3.05M1.2%History
LNTHLantheus Holdings, Inc.Stock30,244$2.50M1.0%History
BMRNBiomarin Pharmaceutical IncCOM25,000$2.43M0.9%History
KRTXKaruna Therapeutics, Inc.COM12,500$2.27M0.9%History
HZNPHorizon Therapeutics Public Ltd CoSHS20,000$2.18M0.8%History
KPTIKaryopharm Therapeutics Inc.COM460,979$1.79M0.7%History
COGTCogent Biosciences, Inc.COM143,064$1.54M0.6%History
NARIInari Medical, Inc.Stock20,000$1.23M0.5%History
PNTPOINT Biopharma Global Inc.COM149,586$1.09M0.4%History
FHTXFoghorn Therapeutics Inc.COM136,771$848.0K0.3%History
ROIVRoivant Sciences Ltd.SHS100,000$738.0K0.3%History
Pieris Pharmaceuticals Inc720795103COM306,950$299.6K0.1%–
SCLXWScilex Holding Co*W EXP 11/10/20218,099$19.0K<0.1%History
SCLXScilex Holding CoCOM463$3.80K<0.1%History